Generic Exposures: Not All Gold Glitters!

Authored by

Vladimir Zdorovtsov, Ph.D.

Senior Vice President, Director, Global Equity Research

Mark Birmingham, CFA

Senior Vice President, Lead Portfolio Manager, Managed Volatility

Key Takeaways

  • Exposures of active portfolios to generic asset pricing factors are often met with skepticism, but their presence does not necessarily imply a lack of proprietary skill or a simplistic investment process.
  • Generic factors can turn into valuable alpha drivers if they reflect proprietary insights and are a deliberate outcome of sophisticated alpha models.
  • By using more sophisticated analytical approaches, one can more effectively differentiate between managers who merely follow generic factors and those who harness them to create genuine alpha.
8 min

Value and Quality Never Go Out of Style

Active managers aim to deliver excess risk-adjusted returns by identifying mispriced securities, constructing portfolios that maximize exposure to these insights, and carefully managing risks and transaction costs. Each manager will look for companies that are cheap, high quality, display strong fundamental growth prospects, and may benefit from favorable market dynamics - although the balance placed on these focuses will depend on a given manager’s style, skill in each respective area, and investment horizon.

Years of empirical research have identified several company characteristics and behavioral anomalies that lead to predictability of excess returns along those four key dimensions. These are abundantly documented and analyzed in journal publications and have served as the foundational pillars for many active managers’ investment processes. While some managers simply offer a cost-effective way of obtaining exposure to these well-known thematic drivers, the overwhelming majority stress a bevy of their own proprietary flavors. Their insights are still rooted in the same general themes but offer superior outcomes by better applying existing data or by tapping into newer, timelier, or more granular information about company fundamentals and actions of market participants.

Getting the Right Answers Starts with Asking the Right Questions

With increasing volume and variety of new “alternative” data sets and the growing sophistication of modeling approaches, active managers are expected to derive more unique and novel alpha insights. It would seem natural to then conclude that their forecasts and portfolios would, correspondingly, show less exposure to well-known constructions that are now deemed generic. Some would even go as far as to say that these exposures should be as low as zero and anything above implies a less sophisticated investment process, one riding on the coattails of generic premia.

Needless to say, anyone looking to invest in an active strategy would want to ensure that it offers unique alpha drivers. Traditional analyses (such as regressing a manager’s ex-post returns on those of generic factors, conducting cross-sectional regressions of forecasts on generic characteristics, and attributing portfolio risk to generic exposures) are at best incomplete and at worst misleading. Instead of focusing solely on measuring a manager’s exposure to generics, the questions and analyses should concentrate on whether these exposures reflect skill.

Don’t Judge a Book by Its Cover

An active portfolio may exhibit exposures to generic factors for several reasons, but only one of them is indicative of the “low proprietary skill manager” problem that is often reflexively assumed to be the cause. These reasons fall into two broad categories. 1) Generic exposures might be embedded upstream in the alpha and then flow through to the portfolio active weights. 2) Even with an alpha forecast entirely devoid of any generic exposures, the portfolio may still acquire such exposures downstream. Let’s consider these in turn.

Will the Real Alpha Signals Please Stand Up?

We begin with the most problematic of all possible scenarios. A manager’s alpha model could rely heavily on persistent linear bets on well-known asset pricing factors as the primary drivers of expected benchmark-relative excess returns. Such exposures would likely be substantial and stable over time, while the resulting return stream would exhibit significant volatility. This would indeed suggest that the manager has low proprietary alpha content. Aside from the aforementioned high and stable loadings on generics, some red flags associated with such managers include low investment in proprietary research efforts (such as human capital, data, technology stack, and an innovative research agenda) and an unwillingness to provide clear and coherent examples of proprietary components in their investment process, often under the guise of intellectual property protection (any “secret sauce” usually can still be intuitively explained in a way that won’t divulge IP). 

Alternatively, an active manager’s exposure to generics could result from explicit or implicit timing components that dynamically shift allocations to align with expected payoffs, an activity which requires considerable skill. Because generics are well known and subject to significant arbitrage activity, they have evolved to behave like risk factors — exhibiting high payoff volatility and carrying premia as compensation for the associated risks. Consequently, predicting changes in their payoffs presents potential alpha opportunities. For example, a manager might employ a proprietary method to model “risk-on” versus “risk-off” environments and then adjust generic exposures to align the portfolio with the expected flow of the “river of risk.”

Lastly, and perhaps most importantly, exposures to generics can result from interaction effects between proprietary alpha components and well-known factors. These interactions can arise in a linear model that includes interaction terms or within a sophisticated nonlinear model that has generic factors among its features. In other words, beyond just when (dynamically timing exposures), the manager can also identify the where and how — specific conditions under which these generics deliver higher and/ or more consistent payoffs. This added layer of insight effectively transforms a common factor into a powerful source of alpha.

Every Rose Has Its Thorns

Even if a manager’s alpha forecast is entirely cleansed of all well-known asset pricing factors, their portfolios may still acquire exposures to such generics downstream. This can happen for several reasons. Portfolio construction constraints often interact with alpha and benchmark properties. For example, a long-only portfolio may struggle to meaningfully underweight small-cap stocks and thus end up overweighting small caps, funded by underweights in large caps, inadvertently creating a bet on the size factor. Similarly, generic factors may be related to alpha dispersion. Whether by explicit design or as a natural outcome of forecast formation, alpha forecasts might be larger in magnitude in the tails of certain generic factors (e.g., more dispersion in less liquid securities). Coupled with other constraints, this can induce generic factor exposures, even if the alpha wasn’t linearly related to these factors.

As another example of generic portfolio exposure not driven by the alpha, consider a portfolio that has enjoyed significant benchmark-relative performance and low turnover due to stable alpha forecasts. Even if this portfolio’s alpha isn’t explicitly betting on generic momentum, it will gradually acquire such exposure unless the risk model or constraints prevent it.

Separating the Wheat from the Chaff

So how can asset owners better identify skilled managers in the context of generic exposures? Let’s start by considering the types of analyses best avoided, which also happen to be those that we see most frequently undertaken: 1) regressing fund performance on the returns of simple factors and 2) assessing the fraction of active risk attributed to generic styles.

While both approaches are easy to implement and may seem intuitive, they can result in misleading conclusions. Looking at the first approach, time series performance attribution may not provide an accurate assessment of a manager’s alpha (as measured by the intercept term) if the regressors are not investable. Care should be taken to ensure that they reflect long investment opportunity in a universe of sufficient liquidity. Additionally, the covariance of ex post payoffs does not necessarily indicate the presence of ex ante exposures. Consider the example of volatility exposure. Large exogenous shocks that disrupt the markets typically degrade the performance of active managers, whether systematic or discretionary. This is intuitive. Performing brain surgery during an earthquake is unlikely to yield good outcomes even for the best of surgeons. Because realized returns often suffer during periods of market turbulence and heightened volatility, a time series regression might suggest that the manager was “selling volatility,” even if their investment process did not involve such exposure ex ante

Looking at the second approach, decomposing active variance provides only a partial view of the drivers of portfolio positioning. Active variance contribution depends on the degree of exposure to a source of risk, its variance, and, to a lesser extent, the correlation of that risk with other drivers of co-movement. Because generic factors are inherently more volatile, they tend to dominate in risk decomposition analyses, even at modest active exposures. Proprietary components are lower volatility in return contribution and less exposed to broad negative events (i.e., exogenous shocks). A proprietary alpha signal that adds a steady excess return will make little contribution to a decomposition of active variance, even if it is a key driver of active weights. 

We recommend a more informative approach where the manager regresses their alpha on generic factors at each point in time and then separately tracks performance of 1) the portion of the alpha explained (“spanned”) by generics and 2) the residual. By construction, the unexplained residual relates to alpha not linearly related to any generic exposures. This residual component should show high efficacy, low risk and a high Sharpe Ratio. The fitted part would still potentially embed manager skill related to temporal variation in exposures to generic factors. Relative to the unexplained residual, it is expected to exhibit lower efficacy and higher volatility. Insofar as the spanned component could involve dynamic exposures to generic factors, assessment of the timing skill that it reflects requires benchmarking its performance relative to some static blend of generic factors. One option would be to use the ex post average of exposures from the regressions, but that implies ex ante foresight as to what those ex post exposures turned out to be. A fairer benchmark would be derived from some simple and transparent static weighting of generic exposures, e.g., a combination that would have generated equal ex ante estimated risk contributions.

Equipped with this separation of forecasts into residual and generic-spanned parts, the manager can assess the sensitivity of portfolio active weights to the two sources of return. Whereas a decomposition of active variance may be dominated by generic exposures, the active tilts of the portfolio (i.e., the portfolio active alpha shares) might more closely reflect the residual forecasts.

Sequentially peeling the layers as described above would allow the manager to provide clear evidence of the value that generic exposures bring to their portfolios and to show the extent to which they are driven by proprietary alpha insights.

Conclusion

Sophisticated systematic investors and consultants are naturally drawn to the narrative that “proprietary” signals offer superior risk-adjusted returns and are the exclusive domain of leading quant firms. Generic exposures within active portfolios are often viewed with suspicion, raising concerns about a lack of proprietary skill. However, as this paper has explored, their presence does not necessarily indicate a simplistic investment process. Instead, these exposures can often be a necessary byproduct of sophisticated alpha models and the interplay between alpha and portfolio construction. When these exposures are driven by proprietary insights, they can enhance excess returns, transforming generic factors into powerful alpha drivers. Stripping them away, while compelling from a marketing perspective, will discard valuable components of the investment process and lead to diminished returns and lost opportunities.

Understanding the true nature of generic exposures requires moving beyond analyses that focus solely on factor loadings or simplistic performance attributions. By relying on more refined but still intuitive methods, asset owners and consultants can better distinguish between managers who simply track generic factors and those who actively leverage them to generate true alpha. 

Legal Disclaimer

These materials provided herein may contain material, non-public information within the meaning of the United States Federal Securities Laws with respect to Acadian Asset Management LLC, BrightSphere Investment Group Inc. and/or their respective subsidiaries and affiliated entities. The recipient of these materials agrees that it will not use any confidential information that may be contained herein to execute or recommend transactions in securities. The recipient further acknowledges that it is aware that United States Federal and State securities laws prohibit any person or entity who has material, non-public information about a publicly-traded company from purchasing or selling securities of such company, or from communicating such information to any other person or entity under circumstances in which it is reasonably foreseeable that such person or entity is likely to sell or purchase such securities.

Acadian provides this material as a general overview of the firm, our processes and our investment capabilities. It has been provided for informational purposes only. It does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or to purchase, shares, units or other interests in investments that may be referred to herein and must not be construed as investment or financial product advice. Acadian has not considered any reader's financial situation, objective or needs in providing the relevant information.

The value of investments may fall as well as rise and you may not get back your original investment. Past performance is not necessarily a guide to future performance or returns. Acadian has taken all reasonable care to ensure that the information contained in this material is accurate at the time of its distribution, no representation or warranty, express or implied, is made as to the accuracy, reliability or completeness of such information.

This material contains privileged and confidential information and is intended only for the recipient/s. Any distribution, reproduction or other use of this presentation by recipients is strictly prohibited. If you are not the intended recipient and this presentation has been sent or passed on to you in error, please contact us immediately. Confidentiality and privilege are not lost by this presentation having been sent or passed on to you in error.

Acadian’s quantitative investment process is supported by extensive proprietary computer code. Acadian’s researchers, software developers, and IT teams follow a structured design, development, testing, change control, and review processes during the development of its systems and the implementation within our investment process. These controls and their effectiveness are subject to regular internal reviews, at least annual independent review by our SOC1 auditor. However, despite these extensive controls it is possible that errors may occur in coding and within the investment process, as is the case with any complex software or data-driven model, and no guarantee or warranty can be provided that any quantitative investment model is completely free of errors. Any such errors could have a negative impact on investment results. We have in place control systems and processes which are intended to identify in a timely manner any such errors which would have a material impact on the investment process.

Acadian Asset Management LLC has wholly owned affiliates located in London, Singapore, and Sydney. Pursuant to the terms of service level agreements with each affiliate, employees of Acadian Asset Management LLC may provide certain services on behalf of each affiliate and employees of each affiliate may provide certain administrative services, including marketing and client service, on behalf of Acadian Asset Management LLC.

Acadian Asset Management LLC is registered as an investment adviser with the U.S. Securities and Exchange Commission. Registration of an investment adviser does not imply any level of skill or training.

Acadian Asset Management (Singapore) Pte Ltd, (Registration Number: 199902125D) is licensed by the Monetary Authority of Singapore. It is also registered as an investment adviser with the U.S. Securities and Exchange Commission.

Acadian Asset Management (Australia) Limited (ABN 41 114 200 127) is the holder of Australian financial services license number 291872 ("AFSL"). It is also registered as an investment adviser with the U.S. Securities and Exchange Commission. Under the terms of its AFSL, Acadian Asset Management (Australia) Limited is limited to providing the financial services under its license to wholesale clients only. This marketing material is not to be provided to retail clients.

Acadian Asset Management (UK) Limited is authorized and regulated by the Financial Conduct Authority ('the FCA') and is a limited liability company incorporated in England and Wales with company number 05644066. Acadian Asset Management (UK) Limited will only make this material available to Professional Clients and Eligible Counterparties as defined by the FCA under the Markets in Financial Instruments Directive, or to Qualified Investors in Switzerland as defined in the Collective Investment Schemes Act, as applicable.

Biographies

Vladimir Zdorovtsov

Vladimir Zdorovtsov, Ph.D.

Senior Vice President, Director, Global Equity Research
Vlad joined Acadian in 2019 and is Director of Global Equity Research. Previously, he was a managing director at Goldman Sachs Asset Management (GSAM), co-leading a quantitative equity research team within the firm’s fundamental equity and direct alternatives units. In this role, Vlad’s focus was on alpha capture and the integration of quantitative alpha, risk, and portfolio construction techniques. Prior to that, he was the head of research at Rosetta Analytics, Inc., a machine learning hedge fund. Vlad received a Ph.D. in finance from the University of South Carolina and holds an M.B.A. from the University of Arkansas as well as a B.A. in international economics from Sumy State University, Ukraine.

Mark Birmingham, CFA

Senior Vice President, Lead Portfolio Manager, Managed Volatility
Mark Birmingham joined Acadian in 2013 and is the Head of Risk Modeling. Before joining Acadian, he was a vice president and quantitative analyst within the quantitative investment group at Wellington Management Co. Mark also served as director, U.S. equity sales and trading at Nomura Securities International, Inc. He earned an A.B. in computer science from Princeton University. Mark is a CFA charterholder and a member of CFA Society Boston.